# Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients

> **NCT02946450** · — · UNKNOWN · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 3000 (estimated)

## Conditions studied

- CT Scanning Patients

## Interventions

- **DRUG:** Other: Not applicable-observational study

## Key facts

- **NCT ID:** NCT02946450
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2016-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02946450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02946450, "Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02946450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*